Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: Evidence from the MIST2 randomised controlled trial.

समान संसाधन

• Intrapleural use of tissue plasminogen activator and DNase in pleural infection
  द्वारा: Rahman, N, और अन्य
  प्रकाशित: (2011)
• Intrapleural use of tissue plasminogen activator and DNase in pleural infection.
  द्वारा: Rahman, N, और अन्य
  प्रकाशित: (2011)
• The biological effect of tissue plasminogen (t-PA) activator and DNase intrapleural delivery in pleural infection patients
  द्वारा: Kanellakis, N, और अन्य
  प्रकाशित: (2018)
• PRIMARY RESULT OF THE SECOND MULTICENTRE INTRAPLEURAL SEPSIS (MIST2) TRIAL; RANDOMISED TRIAL OF INTRAPLEURAL TPA AND DNASE IN PLEURAL INFECTION
  द्वारा: Rahman, N, और अन्य
  प्रकाशित: (2009)
• Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients
  द्वारा: Kanellakis, N, और अन्य
  प्रकाशित: (2019)